(1) The CEO may, in
writing, approve a Schedule 4 poison or Schedule 8 poison (as those terms are
defined in the Medicines and Poisons Act 2014 section 3) for use under this
Act for the purpose of causing a patient’s death.
(2) A poison approved
under subsection (1) is a voluntary assisted dying substance .